LAT-1 expression was significantly increased in tumor tissue compared to non-tumor tissue in both gastrointestinal (67% vs. 44%) and pancreatic NETs (54% vs. 31%). This evidence concerns the gene LAT and pancreatic neuroendocrine tumor.